Kidney Function Numbers Explained: eGFR, Creatinine, CKD Stages, and Drug Dosing

Your Kidneys: Why These Numbers Matter

Your kidneys are two fist-sized organs that perform one of the body's most critical jobs: filtering waste from your blood 24/7. Every day, your kidneys filter about 150 quarts of blood, and the waste and extra water they remove become about 1 to 2 quarts of urine.

Here's the sobering reality: Chronic kidney disease (CKD) affects 37 million American adults—1 in 7 people—yet approximately 90% don't know they have it. Unlike a heart attack with chest pain or diabetes with high blood sugar symptoms, kidney disease is a "silent killer" that often produces no symptoms until 75-90% of kidney function is lost.

The good news: Simple blood and urine tests can detect kidney disease early, when treatment can slow or stop progression. Understanding your kidney function numbers—particularly eGFR (estimated glomerular filtration rate) and creatinine—is critical for:

• Catching kidney disease before irreversible damage occurs
• Properly dosing medications to avoid toxicity
• Identifying cardiovascular disease risk (kidney disease and heart disease are closely linked)
• Making lifestyle changes that preserve remaining kidney function
• Planning for dialysis or transplant if needed

This guide explains what these tests measure, what your results mean, how kidney disease is staged, and when to worry.

Quick Answers: eGFR and Creatinine at a Glance

If you just need fast interpretation before reading the full guide, start here:

• Normal eGFR in healthy younger adults: usually around 90-120 mL/min/1.73m²
• CKD threshold: eGFR <60 for at least 3 months (or other evidence of kidney damage)
• eGFR 60-89: may be normal in some older adults, but concerning if it is declining or albuminuria is present
• Creatinine alone is not enough: age, sex, and muscle mass can make a “normal” creatinine misleading
• Most useful monitoring habit: track trend over time (not one isolated value)

Fast Triage Thresholds

The Key Players: Creatinine, eGFR, and GFR

What Is Creatinine?

Creatinine is a waste product produced by your muscles from the breakdown of a compound called creatine. Your muscles produce creatinine at a fairly constant rate based on muscle mass. This waste travels through your bloodstream to your kidneys, which filter it out and excrete it in urine.

Normal blood creatinine levels:

• Men: 0.74-1.35 mg/dL (65-120 μmol/L)
• Women: 0.59-1.04 mg/dL (52-92 μmol/L)

Women have lower values because they typically have less muscle mass than men.

Why creatinine is used as a kidney marker: Because creatinine is produced at a steady rate and is filtered almost exclusively by the kidneys, blood creatinine levels reflect kidney function. When your kidneys don't work well, creatinine builds up in your blood.

The problem with creatinine alone: Creatinine can remain in the "normal" range until you've lost 50% or more of kidney function. This is because:

• Your body compensates initially
• "Normal ranges" are wide
• Creatinine is influenced by muscle mass, age, sex, diet, and certain medications

Example: A 70-year-old woman with low muscle mass might have a creatinine of 1.0 mg/dL (technically "normal"), but she's actually lost 40% of her kidney function. A muscular 30-year-old man with the same creatinine level might have completely normal kidneys.

This is why we need eGFR.

What Is GFR and eGFR?

Glomerular Filtration Rate (GFR) is the gold standard measurement of kidney function. It tells you how much blood your kidneys filter per minute, measured in milliliters per minute per 1.73 square meters of body surface area (mL/min/1.73m²).

Normal GFR: 90-120 mL/min/1.73m² (healthy young adults)

• This means your kidneys filter 90-120 milliliters of blood every minute
• Over 24 hours, that's about 130-170 liters (34-45 gallons) of blood filtered daily

The problem: Measuring true GFR requires injecting a filtration marker (inulin or iohexol), collecting timed urine samples, and performing complex calculations. It's expensive, time-consuming, and impractical for routine screening.

The solution: Estimated GFR (eGFR)

eGFR uses an equation to estimate your GFR based on:

• Serum creatinine level
• Age
• Sex
• (Sometimes race, though newer equations removed this)

The eGFR calculation takes into account that creatinine levels are influenced by factors other than kidney function, providing a much more accurate assessment than creatinine alone.

Why eGFR is superior to creatinine:

• Detects kidney disease earlier (can identify 25-30% loss of function)
• Accounts for age, sex, and muscle mass differences
• Standardized across populations
• Used universally for CKD staging
• Guides medication dosing

eGFR Equations: Which One Should Be Used?

The Evolution of eGFR Equations

Multiple equations have been developed to estimate GFR, each with strengths and limitations:

1. CKD-EPI 2021 Equation (Current Gold Standard)

The 2021 CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation is the equation recommended for use in the United States by the 2021 NKF-ASN Task Force. KDIGO 2024 does not mandate a single equation: it recommends a validated, race-free equation used consistently within each region, and accepts both CKD-EPI and EKFC equations.

Key features:

• Race-free formula - Removed the race coefficient from the 2009 version
• More accurate than MDRD, especially when eGFR >60
• Reduced bias across diverse populations
• Recommended by National Kidney Foundation and American Society of Nephrology

When to use: Primary equation for all adults

Formula: Uses serum creatinine, age, and sex (complex calculation performed by labs and calculators)

Accuracy: about 85-90% of estimates within ±30% of measured GFR in the 2021 validation data

2. MDRD Equation (Older, Less Accurate)

The Modification of Diet in Renal Disease (MDRD) Study equation was developed in 1999 and widely used until 2012.

Key features:

• Uses creatinine, age, sex, and race
• Accurate for eGFR <60 mL/min/1.73m²
• Underestimates kidney function when eGFR >60
• Being phased out in favor of CKD-EPI

When it's still used: Some older drug dosing guidelines reference MDRD

Why it's outdated: Less accurate than CKD-EPI 2021, perpetuated race-based medicine without biological justification

3. Cockcroft-Gault Equation (For Creatinine Clearance, Not eGFR)

The Cockcroft-Gault equation estimates creatinine clearance (CrCl), not GFR. It's from 1976 but still used for medication dosing.

Key features:

• Uses creatinine, age, sex, and actual body weight
• Not adjusted for body surface area (reports mL/min, not mL/min/1.73m²)
• Measured creatinine clearance overestimates GFR by 10-40% because creatinine is also secreted by kidney tubules; the Cockcroft-Gault estimate can still read lower than eGFR in older, low-weight people

When to use:

• Many drug dosing guidelines were developed using Cockcroft-Gault
• Particularly for drugs with narrow therapeutic windows

Why it differs from eGFR: CrCl ≠ eGFR. The two can differ substantially in either direction: Cockcroft-Gault often reads higher than eGFR in younger or heavier people and lower in older, low-weight people.

4. EKFC 2021 Equation (European Alternative)

The European Kidney Function Consortium (EKFC) equation is the European equivalent of CKD-EPI 2021.

Key features:

• Similar accuracy to CKD-EPI 2021
• Race-free
• Used primarily in Europe

When to use: Acceptable alternative to CKD-EPI 2021

CKD-EPI 2021 vs. MDRD vs. Cockcroft-Gault: Quick Comparison

Bottom line: Request eGFR using CKD-EPI 2021 from your healthcare provider. If only MDRD is available and your eGFR is >60, it's likely underestimated.

Understanding Your eGFR Result: CKD Staging (KDIGO 2024)

The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guidelines classify chronic kidney disease into stages based on eGFR and albuminuria (protein in urine).

CKD Stages by eGFR (G Stages)

Important notes:

CKD requires ≥3 months duration: A single low eGFR doesn't mean CKD. Acute kidney injury (AKI) from dehydration, infection, or medications can temporarily lower eGFR. CKD is diagnosed when kidney damage or eGFR <60 persists for ≥3 months.

Albuminuria (protein in urine) matters too: The complete CKD classification includes both eGFR (G stage) and albuminuria (A stage):

• A1: <30 mg/g (normal to mildly increased)
• A2: 30-300 mg/g (moderately increased) - microalbuminuria
• A3: >300 mg/g (severely increased) - macroalbuminuria

Risk increases with both lower eGFR and higher albuminuria. Someone with G3aA3 (eGFR 50, albuminuria 500 mg/g) has much higher risk than someone with G3aA1 (eGFR 50, albuminuria 10 mg/g).

Age-Related eGFR Decline: When to Worry

Normal aging causes gradual eGFR decline:

• Healthy kidneys lose approximately 0.75-1 mL/min/1.73m² per year after age 40
• A 70-year-old with eGFR 65 may have age-appropriate kidney function
• A 30-year-old with eGFR 65 has significant kidney disease

When eGFR 60-89 is concerning:

• Rapid decline (>5 mL/min/1.73m² per year)
• Albuminuria present (even small amounts)
• Young age (<50 years)
• Known kidney disease risk factors (diabetes, hypertension, family history)

When eGFR 60-89 may be normal:

• Older adults (>70) with stable values
• No albuminuria
• No other kidney damage markers

eGFR vs. Creatinine Clearance: When to Use Each

This is one of the most confusing aspects of kidney function testing. Here's when to use which:

Use eGFR (CKD-EPI 2021) for:

✅ CKD diagnosis and staging - Universal standard ✅ Monitoring kidney disease progression - Serial measurements over time ✅ General kidney function assessment - Routine screening ✅ Most medication dosing - Increasingly used in modern drug labels ✅ Risk stratification - Cardiovascular and mortality risk

Why: More accurate, standardized, doesn't require urine collection, accounts for individual factors

Use Creatinine Clearance (CrCl) for:

✅ Medication dosing - When drug labels specifically reference CrCl (Cockcroft-Gault) ✅ Drugs with narrow therapeutic windows - Vancomycin, aminoglycosides, chemotherapy ✅ Older drug formulations - Many drugs approved before 2010 used Cockcroft-Gault in trials

Why: Drug dosing recommendations were developed using CrCl; switching to eGFR might alter dosing

Which is higher? It depends on the patient. Measured creatinine clearance overestimates true GFR because:

• CrCl includes both filtration and tubular secretion of creatinine
• eGFR estimates filtration only

But the Cockcroft-Gault estimate also depends on age and actual body weight, so it can come out higher or lower than eGFR.

Example:

• Patient: 75-year-old woman, creatinine 1.2 mg/dL, weight 60 kg
• eGFR (CKD-EPI 2021): 47 mL/min/1.73m² (Stage G3a)
• CrCl (Cockcroft-Gault): 38 mL/min (lower in this case due to older age and low body weight)

The Medication Dosing Dilemma

The problem: Drug labels approved before 2012 used Cockcroft-Gault CrCl for dosing cutoffs. Newer drugs often use CKD-EPI eGFR. Your lab reports eGFR, but some drug references want CrCl.

What to do:

1. Check the drug label or dosing guideline - Does it reference eGFR or CrCl?
2. For critical drugs near a dosing cutoff - Calculate both eGFR and CrCl; use the more conservative (lower) value
3. When eGFR and CrCl disagree significantly - Consult a pharmacist or use the combined eGFRcr-cys (creatinine + cystatin C) for highest accuracy
4. For most common medications - eGFR is acceptable

High-risk medications requiring kidney-based dosing:

• Antibiotics: Vancomycin, aminoglycosides (gentamicin, tobramycin), fluoroquinolones
• Anticoagulants: Dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), edoxaban (Savaysa)
• Diabetes medications: Metformin (contraindicated if eGFR <30), SGLT2 inhibitors
• Chemotherapy: Carboplatin, methotrexate, many others
• Antivirals: Acyclovir, ganciclovir, tenofovir
• Others: Lithium, digoxin, gabapentin, baclofen

The golden rule: When your eGFR is near a dosing cutoff (e.g., 30, 45, or 60 mL/min/1.73m²), your doctor or pharmacist should carefully verify which equation the drug label used and dose accordingly.

Cystatin C: The More Accurate (But Expensive) Alternative

Cystatin C is a protein produced by all cells in the body at a constant rate. Like creatinine, it's filtered by the kidneys and can be used to estimate GFR.

Advantages over creatinine:

• Not affected by muscle mass - More accurate in elderly, malnourished, or very muscular individuals
• Detects kidney disease earlier - More sensitive to small changes in kidney function
• Less affected by diet - Creatinine can be elevated after eating red meat

Disadvantages:

• More expensive - Not routinely covered by insurance for screening
• Less widely available - Not all labs offer it
• Affected by other factors - Thyroid disease, corticosteroid use, inflammation

Combined eGFR (Creatinine + Cystatin C): The Most Accurate

The KDIGO 2024 guidelines recommend:

• Use eGFRcr (creatinine-based) for initial assessment
• When eGFRcr is likely to be inaccurate and GFR affects clinical decisions, measure cystatin C and use the combined eGFRcr-cys equation
• Reserve eGFRcys (cystatin C alone) for specific situations, such as otherwise healthy people with very low muscle mass

When to add cystatin C:

• eGFR near a critical threshold (e.g., 58 mL/min when 60 is a treatment cutoff)
• Extremes of muscle mass (bodybuilders, elderly, amputees, malnutrition)
• Medication dosing for drugs with narrow therapeutic windows
• Confirming G3a CKD before starting treatments

The combined equation (eGFRcr-cys) is the most accurate, with >90% of estimates within ±30% of measured GFR in the 2021 validation data.

What Causes Low eGFR? Common Kidney Disease Causes

Understanding why your eGFR is low helps guide treatment:

Primary Kidney Diseases

Diabetic kidney disease (diabetic nephropathy):

• Leading cause of kidney failure (ESKD) in the United States (about 47% of new cases in 2019)
• High blood sugar damages kidney filters over years
• Often asymptomatic until advanced
• Prevention: Individualized glucose control (KDIGO HbA1c target range <6.5% to <8.0%), blood pressure <130/80, ACE inhibitors or ARBs

Hypertensive kidney disease (hypertensive nephrosclerosis):

• Second leading cause (about 29% of new kidney failure cases in 2019)
• Chronic high blood pressure damages kidney blood vessels
• Prevention: Blood pressure <130/80, lifestyle modifications, antihypertensives

Glomerulonephritis:

• Inflammation of kidney filters (glomeruli)
• Can be autoimmune (IgA nephropathy, lupus nephritis) or infectious
• Often presents with blood and protein in urine

Polycystic kidney disease (PKD):

• Genetic disorder causing fluid-filled cysts in kidneys
• Autosomal dominant PKD affects 1 in 400-1,000 people
• Gradual kidney enlargement and function loss

Secondary Causes

• Acute kidney injury (AKI) leading to CKD - Severe infections, medications, dehydration
• Obstructive uropathy - Kidney stones, enlarged prostate, tumors blocking urine flow
• Recurrent kidney infections - Chronic pyelonephritis
• Medications - NSAIDs (ibuprofen, naproxen), certain antibiotics, proton pump inhibitors (long-term)
• Cardiovascular disease - Heart failure reduces kidney blood flow

Risk Factors for CKD

• Diabetes
• Hypertension
• Age >60
• Family history of kidney disease
• Obesity
• Smoking
• Cardiovascular disease
• Frequent NSAID use
• African American, Hispanic, Asian, or Native American ancestry (higher genetic risk)

Symptoms of Kidney Disease: When to Worry

Early CKD (stages G1-G3a) usually has NO symptoms. This is why screening is critical.

Symptoms appear in stages G3b-G5:

Fluid retention:

• Swelling in ankles, feet, hands, face (especially morning puffiness around eyes)
• Shortness of breath (fluid in lungs)
• Weight gain from fluid

Urination changes:

• Foamy urine (protein in urine)
• Blood in urine (pink, red, or cola-colored)
• Frequent urination, especially at night (nocturia)
• Decreased urine output

Fatigue and weakness:

• Anemia (kidneys produce erythropoietin, which stimulates red blood cell production)
• Feeling cold all the time

Digestive symptoms:

• Loss of appetite
• Nausea and vomiting
• Metallic taste in mouth
• Weight loss

Skin changes:

• Severe itching (uremic pruritis from waste buildup)
• Dry skin
• Yellow-brown skin tone

Neurological symptoms:

• Difficulty concentrating ("brain fog")
• Sleep problems
• Muscle cramps
• Restless legs
• Numbness or tingling

Severe symptoms (stage G5, uremia):

• Confusion or altered mental status
• Seizures
• Coma
• Difficulty breathing
• Chest pain (pericarditis)

⚠️ If you experience these symptoms with known kidney disease, seek immediate medical attention.

How to Protect Your Kidneys: Prevention and Slowing Progression

Even if you have CKD, the right interventions can slow or stop progression to kidney failure.

1. Control Blood Pressure (Target: <130/80 mmHg)

Why it matters: High blood pressure damages kidney blood vessels and accelerates CKD progression.

What to do:

• Monitor blood pressure at home
• Take prescribed antihypertensives consistently
• Ask about your personal target: the 2025 AHA/ACC guideline uses <130/80 for most adults, while KDIGO suggests a systolic target <120 mmHg in CKD when tolerated (using standardized office measurement)
• ACE inhibitors or ARBs are preferred for CKD patients (protect kidneys beyond blood pressure control)
• Limit sodium to <2,000 mg/day (KDIGO 2024 suggestion for people with CKD)
• DASH diet (Dietary Approaches to Stop Hypertension)

2. Control Blood Sugar (Individualized HbA1c Target if Diabetic)

Why it matters: High blood sugar causes diabetic kidney disease through multiple mechanisms.

What to do:

• Monitor blood glucose regularly
• Agree on an HbA1c target with your clinician: KDIGO 2022 recommends an individualized target ranging from <6.5% to <8.0% in people with diabetes and CKD
• Take diabetes medications as prescribed
• SGLT2 inhibitors (empagliflozin, dapagliflozin) and GLP-1 agonists (semaglutide, dulaglutide) protect kidneys in diabetics
• KDIGO 2024 also recommends SGLT2 inhibitors for many adults with CKD who do not have diabetes (eGFR ≥20 with urine ACR ≥200 mg/g, or heart failure)
• Limit refined carbohydrates and added sugars

3. Take ACE Inhibitors or ARBs (If Prescribed)

Medications:

• ACE inhibitors: Lisinopril, enalapril, ramipril
• ARBs: Losartan, valsartan, irbesartan

Why they're protective:

• Lower pressure in kidney filters
• Reduce albuminuria
• Slow CKD progression, especially when albuminuria is present
• Protect against cardiovascular events

When to use: KDIGO 2024 recommends them for CKD with albuminuria (A2 or A3), most strongly for A3 or when diabetes is present; they are also used for hypertension or heart failure

Important: An early rise in creatinine is expected; KDIGO 2024 advises continuing unless creatinine rises by more than 30% within 4 weeks of starting or increasing the dose. Don't stop without consulting your doctor

4. Avoid Nephrotoxic Medications

Kidney-damaging drugs:

• NSAIDs: Ibuprofen, naproxen, ketorolac (use acetaminophen instead)
• Aminoglycoside antibiotics: Gentamicin, tobramycin (monitor levels)
• Contrast dye: Used in CT scans (ensure hydration before/after)
• Proton pump inhibitors (PPIs): Long-term use linked to CKD (use lowest effective dose)
• Herbal supplements: Some contain nephrotoxins (aristolochic acid in some Chinese herbs)

Always inform healthcare providers of your eGFR before starting new medications.

5. Dietary Modifications

For early CKD (G1-G3a):

• Limit sodium <2,000 mg/day
• Adequate but not excessive protein (about 0.8 g/kg/day; avoid >1.3 g/kg/day if at risk of progression)
• DASH diet or Mediterranean diet
• Stay hydrated (unless told to restrict fluids)

For advanced CKD (G4-G5):

• Keep protein around 0.8 g/kg/day (KDIGO 2024); lower-protein diets only under close dietitian supervision
• Limit phosphorus (avoid processed foods, cola, dairy in excess)
• Limit potassium (avoid bananas, oranges, tomatoes, potatoes if high)
• May need fluid restriction if swelling occurs

6. Treat Underlying Conditions

• Diabetes: Optimize glucose control
• Hypertension: Control blood pressure
• High cholesterol: Statins reduce cardiovascular risk (CKD patients are at very high CV risk)
• Anemia: Treat with iron supplementation or erythropoiesis-stimulating agents (ESAs)
• Bone disease: Calcium, vitamin D, phosphate binders

7. Lifestyle Modifications

• Quit smoking - Accelerates CKD progression
• Maintain healthy weight - Obesity worsens CKD
• Exercise regularly - 30+ minutes most days (as tolerated)
• Limit alcohol - the 2025-2030 Dietary Guidelines for Americans no longer set a daily drink number and simply advise drinking less
• Avoid dehydration - Drink water, especially before exercise or in heat

When to See a Nephrologist

Not everyone with mildly reduced eGFR needs a kidney specialist, but certain situations warrant referral:

Refer to nephrologist if:

• eGFR <30 (stage G4 or G5)
• 5-year risk of kidney failure above 3-5% on a validated risk equation (such as the Kidney Failure Risk Equation)
• eGFR 30-59 with rapidly declining kidney function (>5 mL/min/year)
• Albuminuria ≥300 mg/g together with hematuria, or consistently >700 mg/g
• Albuminuria 30-300 mg/g with declining eGFR
• Blood in urine (hematuria) with no obvious cause
• Difficult-to-control blood pressure despite 4+ medications
• Suspected glomerulonephritis or other primary kidney disease
• Hereditary kidney disease (polycystic kidney disease, Alport syndrome)
• Chronic kidney disease in young adults (<30 years)
• Kidney stones requiring complex management
• Planning for kidney replacement therapy (dialysis, transplant)

Early nephrology referral improves outcomes by:

• Slowing CKD progression with specialized treatments
• Managing complications (anemia, bone disease, electrolyte imbalances)
• Preparing for kidney replacement therapy (dialysis access, transplant evaluation)
• Avoiding preventable complications

Related Kidney and Electrolyte Guides

Use these companion pages to move from a lab abnormality to a practical next step:

• eGFR vs Creatinine Clearance - Which value to use for CKD staging versus medication dosing
• Nephrology Calculator Guide - High-yield kidney tools for AKI, CKD, and volume assessment
• Electrolyte Disorders Guide - Sodium, potassium, calcium, and acid-base interpretation
• Clinical Calculator Guide - Broader internal medicine workflows linked to kidney function

Kidney Function Calculators: Your Complete Toolkit

Use these calculators to assess and monitor kidney function:

1. eGFR Calculator (CKD-EPI 2021) - Primary tool for estimating kidney function and CKD staging
2. Creatinine Clearance (Cockcroft-Gault) - For medication dosing when drug labels reference CrCl
3. 24-Hour Creatinine Clearance - Most accurate CrCl using 24-hour urine collection
4. BUN/Creatinine Ratio - Helps distinguish prerenal from intrinsic kidney injury
5. FENa Calculator - Fractional excretion of sodium; differentiates prerenal AKI from acute tubular necrosis

Kidney Function FAQ (Practical)

Is eGFR 60 dangerous?

Not always. eGFR around 60 can be stable and lower-risk in some older adults, but it becomes more concerning when it is declining, when urine albumin is elevated, or when other risk factors (diabetes, hypertension, family history) are present.

Can eGFR improve?

Sometimes. eGFR can improve if a reversible cause is treated (dehydration, medication effect, uncontrolled blood pressure, hyperglycemia, urinary obstruction). Chronic structural CKD is usually not “cured,” but progression can often be slowed substantially.

Which is more important: creatinine or eGFR?

For most people, eGFR is more clinically useful than creatinine alone because it adjusts for age and sex. Creatinine is still important, but should usually be interpreted together with eGFR and urine albumin.

How often should kidney labs be repeated?

If you are low risk and normal, often yearly or per routine preventive care. If eGFR is reduced, albuminuria is present, or risk factors are significant, repeat frequency is usually every 3-12 months depending on stage and stability.

What should I avoid if kidney function is reduced?

Avoid unnecessary NSAID use, dehydration, and unreviewed supplements. Ask for kidney-safe medication dosing and contrast-risk planning before imaging. Bring your recent eGFR/creatinine values to appointments.

Does one abnormal result mean CKD?

No. CKD diagnosis generally requires persistence for at least 3 months (or clear structural/urinary evidence of kidney damage). A single abnormal value should usually be rechecked and interpreted in context.

The Bottom Line: Know Your Numbers

Your kidneys are silent until they fail. By the time you feel symptoms, you may have lost 75-90% of function.

What you need to know:

• Get tested: Annual blood creatinine and eGFR if you have diabetes, hypertension, or family history of kidney disease
• Understand your eGFR: Normal is >90; worry if <60 (especially under age 60)
• Check for albuminuria: Urine albumin-to-creatinine ratio should be <30 mg/g
• Monitor trends: Declining eGFR over time is more concerning than a single low value
• Don't ignore stage G3a: Even "mild" kidney disease increases cardiovascular risk and requires action

Early detection and treatment can preserve kidney function for decades. Control blood pressure, manage diabetes, avoid nephrotoxic drugs, and work with your healthcare team.

If your eGFR is <60 for >3 months, you have chronic kidney disease. This isn't a death sentence—it's a call to action. With the right interventions, most people with CKD never progress to dialysis.

---

Sources

Research for this guide was based on the latest 2024-2026 kidney disease guidelines:

• KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
• CKD-EPI Creatinine Equation (2021) | National Kidney Foundation
• Determining Drug Dosing in Adults with Chronic Kidney Disease - NIDDK
• Evaluation and Management of Chronic Kidney Disease: Synopsis of the KDIGO 2024 Clinical Practice Guideline | Annals of Internal Medicine
• KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
• Chronic Kidney Disease in the United States | CDC
• Reported Cases of End-Stage Kidney Disease, United States, 2000-2019 | CDC MMWR
• Your Kidneys & How They Work | NIDDK